SCANGOS GEORGE A
Insider CIK 1202102 · A Director · VYGR Director · VIR President and CEO, Director · BIIB Chief Executive Officer, Director · EXEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2026-03-19 | 2026-03-23 | 2,158 | $111.75 | $241.2K | 22,800 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2026-03-19 | 2026-03-23 | 1,057 | $111.75 | $118.1K | 23,857 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2025-06-03 | 2025-06-04 | 24,000 | — | $0 | 24,000 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2025-03-14 | 2025-03-18 | 1,819 | $121.18 | $220.4K | 20,493 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2025-02-24 | 2025-02-25 | 10,056 | $9.45 | $95.0K | 698,239 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2025-02-18 | 2025-02-19 | 10,964 | $9.81 | $107.6K | 708,295 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2024-10-23 | 2024-10-24 | 598,270 | — | $0 | 598,270 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2024-10-23 | 2024-10-24 | 598,270 | — | $0 | 719,259 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2024-10-23 | 2024-10-24 | 598,270 | — | $0 | 1,151,730 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2024-10-23 | 2024-10-24 | 598,270 | — | $0 | 1,151,730 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 24,000 | — | $0 | 24,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2024-05-30 | 2024-06-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2024-05-30 | 2024-06-03 | 8,000 | — | $0 | 120,989 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | G Gift | 2024-05-29 | 2024-05-31 | 3,443 | $145.48 | $500.9K | 17,893 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | G Gift | 2024-05-29 | 2024-05-31 | 3,443 | $145.48 | $500.9K | 18,578 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2024-03-15 | 2024-03-19 | 1,678 | $147.48 | $247.5K | 21,989 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2024-02-26 | 2024-02-26 | 17,722 | $11.65 | $206.5K | 112,989 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2024-02-22 | 2024-02-26 | 10,028 | $10.05 | $100.8K | 130,711 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2024-02-20 | 2024-02-20 | 16,872 | $10.22 | $172.4K | 140,739 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2024-02-16 | 2024-02-20 | 10,878 | $10.24 | $111.4K | 157,611 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-10-17 | 2023-10-18 | 1,750,000 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-10-17 | 2023-10-18 | 1,750,000 | — | $0 | 1,750,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-10-17 | 2023-10-18 | 1,750,000 | — | $0 | 1,750,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-10-17 | 2023-10-18 | 1,750,000 | — | $0 | 168,489 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-09-15 | 2023-09-18 | 827,151 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-09-15 | 2023-09-18 | 111,644 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-09-15 | 2023-09-18 | 1,750,000 | — | $0 | 1,750,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-09-15 | 2023-09-18 | 1,750,000 | — | $0 | 1,918,489 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-09-15 | 2023-09-18 | 3,500,000 | — | $0 | 33,629 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-09-15 | 2023-09-18 | 111,644 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-09-15 | 2023-09-18 | 827,151 | — | $0 | 0 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-07 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2023-05-09 | 2023-05-11 | 44,000 | — | $0 | 44,000 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2023-03-16 | 2023-03-20 | 1,658 | $136.82 | $226.8K | 20,185 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-02-24 | 2023-02-24 | 10,880 | $23.56 | $256.3K | 168,489 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-02-24 | 2023-02-24 | 4,239 | $22.74 | $96.4K | 179,369 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-02-23 | 2023-02-24 | 12,631 | $25.97 | $328.0K | 183,608 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-02-21 | 2023-02-21 | 6,474 | $28.80 | $186.5K | 196,239 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-02-21 | 2023-02-21 | 11,382 | $28.02 | $318.9K | 202,713 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2023-02-17 | 2023-02-21 | 9,894 | $25.29 | $250.2K | 214,095 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-01-18 | 2023-02-21 | 64,930 | — | $0 | 179,930 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2023-01-18 | 2023-02-21 | 64,930 | — | $0 | 3,533,629 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-12-21 | 2023-02-21 | 49,984 | — | $0 | 111,644 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-12-21 | 2023-02-21 | 49,984 | — | $0 | 827,151 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-12-21 | 2023-02-21 | 49,984 | — | $0 | 111,644 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-12-21 | 2023-02-21 | 49,984 | — | $0 | 827,151 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2022-03-17 | 2022-03-21 | 1,785 | $136.82 | $244.2K | 18,420 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2022-03-10 | 2022-04-06 | 222,000 | — | $0 | 222,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2022-03-10 | 2022-04-06 | 111,000 | — | $0 | 223,989 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-02-18 | 2022-02-22 | 17,726 | $30.65 | $543.3K | 112,989 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2022-02-17 | 2022-02-22 | 10,024 | $31.93 | $320.1K | 130,715 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2021-03-18 | 2021-03-22 | 986 | $121.59 | $119.9K | 16,544 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2021-03-18 | 2021-03-22 | 1,850 | $121.59 | $224.9K | 15,558 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2021-02-16 | 2021-02-18 | 222,000 | — | $0 | 222,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2021-02-16 | 2021-02-18 | 111,000 | — | $0 | 4,609,559 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2020-08-03 | 2020-08-05 | 177 | $93.91 | $16.6K | 28,112 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-05-18 | 2020-05-20 | 75,000 | $25.96 | $1.95M | 714,717 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2020-05-15 | 2020-05-15 | 21,686 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2020-05-15 | 2020-05-15 | 30,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2020-05-15 | 2020-05-15 | 30,000 | $4.58 | $137.4K | 768,031 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2020-05-15 | 2020-05-15 | 21,686 | $5.82 | $126.2K | 789,717 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-04-24 | 2020-04-24 | 15,000 | $26.24 | $393.6K | 738,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-04-23 | 2020-04-24 | 44,300 | $25.68 | $1.14M | 808,731 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-04-23 | 2020-04-24 | 55,700 | $26.23 | $1.46M | 753,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-04-22 | 2020-04-22 | 4,200 | $25.05 | $105.2K | 853,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-04-21 | 2020-04-22 | 5,800 | $25.04 | $145.2K | 857,231 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-04-20 | 2020-04-22 | 5,900 | $24.70 | $145.7K | 863,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-04-20 | 2020-04-22 | 25,600 | $24.07 | $616.2K | 868,931 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-04-20 | 2020-04-22 | 18,500 | $23.39 | $432.7K | 894,531 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2020-04-17 | 2020-04-21 | 1,027 | $73.01 | $75.0K | 27,887 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2020-04-17 | 2020-04-21 | 3,081 | $73.01 | $224.9K | 26,860 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-04-15 | 2020-04-17 | 25,000 | $18.31 | $457.7K | 913,031 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2020-04-14 | 2020-04-16 | 236,806 | $29.56 | $7.00M | 1,907,329 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2020-04-14 | 2020-04-16 | 236,806 | $29.56 | $7.00M | 4,713,559 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-04-08 | 2020-04-09 | 7,065 | $18.35 | $129.6K | 938,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-04-07 | 2020-04-09 | 16,435 | $18.25 | $299.9K | 945,096 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-03-31 | 2020-04-02 | 1,500 | $18.06 | $27.1K | 961,531 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-02-18 | 2020-02-21 | 50,000 | $20.73 | $1.04M | 963,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-02-12 | 2020-02-12 | 21,000 | $20.02 | $420.4K | 1,013,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-02-11 | 2020-02-12 | 4,000 | $20.14 | $80.6K | 1,034,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-01-22 | 2020-01-24 | 25,000 | $19.75 | $493.8K | 1,038,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-01-15 | 2020-01-17 | 25,000 | $20.39 | $509.8K | 1,063,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-12-27 | 2019-12-27 | 25,000 | $18.25 | $456.3K | 1,090,531 | SEC↗ |
| EXEL EXELIXIS, INC. | G Gift | 2019-12-12 | 2019-12-27 | 12,500 | — | $0 | 1,115,531 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-08-01 | 2019-08-02 | 6,050 | $21.23 | $128.4K | 1,128,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-08-01 | 2019-08-02 | 33,950 | $20.48 | $695.3K | 1,134,081 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-07-01 | 2019-07-03 | 40,000 | $21.58 | $863.2K | 1,168,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-06-04 | 2019-06-05 | 15,000 | $20.00 | $300.0K | 1,208,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-06-03 | 2019-06-05 | 25,000 | $19.61 | $490.3K | 1,223,031 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2019-05-23 | 2019-05-24 | 42,641 | — | $0 | 42,641 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2019-05-21 | 2019-05-22 | 15,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2019-05-21 | 2019-05-22 | 15,000 | $4.57 | $68.5K | 1,248,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-05-02 | 2019-05-03 | 15,000 | $20.00 | $300.0K | 1,233,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-05-01 | 2019-05-03 | 25,000 | $19.75 | $493.8K | 1,248,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-04-03 | 2019-04-03 | 5,000 | $25.03 | $125.2K | 1,273,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-04-01 | 2019-04-03 | 40,000 | $24.02 | $960.8K | 1,278,031 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2019-03-21 | 2019-03-22 | 1,255 | $82.00 | $102.9K | 23,699 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2019-03-21 | 2019-03-22 | 2,823 | $82.00 | $231.5K | 22,444 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-03-14 | 2019-03-15 | 5,000 | $25.00 | $125.0K | 1,318,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-03-01 | 2019-03-01 | 40,000 | $22.66 | $906.4K | 1,323,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-02-01 | 2019-02-01 | 40,000 | $23.53 | $941.2K | 1,363,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-01-03 | 2019-01-04 | 96 | $20.00 | $1.9K | 1,403,031 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-01-02 | 2019-01-04 | 39,904 | $19.64 | $783.7K | 1,403,127 | SEC↗ |
| EXEL EXELIXIS, INC. | G Gift | 2018-12-15 | 2019-01-04 | 9,300 | — | $0 | 1,443,031 | SEC↗ |
| EXEL EXELIXIS, INC. | G Gift | 2018-12-15 | 2019-01-04 | 4,650 | — | $0 | 1,452,331 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2018-12-03 | 2018-12-03 | 40,000 | $21.16 | $846.4K | 1,456,981 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2018-11-30 | 2018-12-03 | 8,500 | $20.00 | $170.0K | 1,496,981 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2018-11-29 | 2018-12-03 | 6,500 | $20.00 | $130.0K | 1,505,481 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2018-11-01 | 2018-11-02 | 10,000 | $14.14 | $141.4K | 1,511,981 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2018-11-01 | 2018-11-02 | 15,000 | $15.00 | $225.0K | 1,521,981 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2018-10-01 | 2018-10-03 | 25,000 | $17.86 | $446.5K | 1,536,981 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2018-09-24 | 2018-09-26 | 25,000 | $16.85 | $421.3K | 1,561,981 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2018-08-10 | 2018-08-10 | 75,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2018-08-10 | 2018-08-10 | 33,333 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2018-08-10 | 2018-08-10 | 75,000 | $5.04 | $378.0K | 1,553,648 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2018-08-10 | 2018-08-10 | 33,333 | $4.42 | $147.3K | 1,586,981 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2018-05-24 | 2018-05-24 | 31,167 | — | $0 | 31,167 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2018-05-15 | 2018-05-16 | 15,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2018-05-15 | 2018-05-16 | 15,000 | $11.66 | $174.9K | 1,478,648 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2018-03-22 | 2018-03-23 | 2,876 | $67.47 | $194.0K | 18,136 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2018-03-22 | 2018-03-23 | 1,438 | $67.47 | $97.0K | 19,574 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2017-05-25 | 2017-05-26 | 23,491 | — | $0 | 23,491 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2017-03-16 | 2017-03-17 | 3,866 | $53.05 | $205.1K | 15,253 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2016-12-07 | 2016-12-07 | 356 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2016-12-07 | 2016-12-07 | 356 | $8.99 | $3.2K | 1,463,824 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2016-12-07 | 2016-12-07 | 176 | $17.90 | $3.2K | 1,463,648 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2016-12-05 | 2016-12-07 | 357,976 | — | $0 | 356 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2016-12-05 | 2016-12-07 | 204,718 | $17.81 | $3.65M | 1,463,468 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2016-12-05 | 2016-12-07 | 357,976 | $8.99 | $3.22M | 1,668,186 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-07-21 | 2016-07-22 | 157 | $280.00 | $44.0K | 54,779 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-06-03 | 2016-06-06 | 842 | $290.00 | $244.2K | 54,936 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-06-01 | 2016-06-02 | 487 | $287.97 | $140.2K | 55,778 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-05-31 | 2016-06-02 | 3,368 | $290.00 | $976.7K | 56,265 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2016-05-26 | 2016-05-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-05-25 | 2016-05-27 | 157 | $280.00 | $44.0K | 59,633 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-05-02 | 2016-05-04 | 487 | $274.74 | $133.8K | 59,790 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-04-06 | 2016-04-07 | 157 | $280.00 | $44.0K | 60,277 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-04-01 | 2016-04-05 | 487 | $258.83 | $126.1K | 60,434 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2016-03-17 | 2016-03-18 | 4,704 | $39.29 | $184.8K | 11,378 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-03-01 | 2016-03-03 | 487 | $261.37 | $127.3K | 60,921 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-23 | 2016-02-25 | 2,964 | — | $0 | 23,586 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-23 | 2016-02-25 | 5,884 | — | $0 | 17,702 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-23 | 2016-02-25 | 1,395 | $258.99 | $361.3K | 61,417 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-23 | 2016-02-25 | 2,964 | — | $0 | 62,812 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2016-02-22 | 2016-02-24 | 40,460 | — | $0 | 40,460 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2016-02-17 | 2016-02-19 | 487 | $256.16 | $124.7K | 59,848 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-12 | 2016-02-17 | 5,982 | — | $0 | 10,502 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-12 | 2016-02-17 | 4,512 | — | $0 | 16,484 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-12 | 2016-02-17 | 9,189 | — | $0 | 9,182 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 5,359 | $247.22 | $1.32M | 60,335 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2016-02-12 | 2016-02-17 | 11,390 | — | $0 | 65,694 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 4,324 | $247.22 | $1.07M | 54,304 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-12 | 2016-02-17 | 9,189 | — | $0 | 58,628 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 2,132 | $247.22 | $527.1K | 49,439 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-12 | 2016-02-17 | 4,512 | — | $0 | 51,571 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-09 | 2016-02-10 | 11,274 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-09 | 2016-02-10 | 11,274 | — | $0 | 52,364 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-09 | 2016-02-10 | 5,305 | $249.99 | $1.33M | 47,059 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2016-01-04 | 2016-01-05 | 6,383 | — | $0 | 1,310,210 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2015-06-01 | 2015-06-02 | 1,362 | $398.87 | $543.3K | 41,090 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2015-05-28 | 2015-05-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2015-05-01 | 2015-05-05 | 1,362 | $377.52 | $514.2K | 42,452 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2015-04-01 | 2015-04-02 | 1,362 | $423.20 | $576.4K | 43,814 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2015-03-19 | 2015-03-20 | 4,311 | $42.21 | $182.0K | 6,666 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-13 | 2015-03-16 | 537 | $412.69 | $221.6K | 45,176 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-02 | 2015-03-03 | 825 | $410.67 | $338.8K | 45,713 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2015-02-23 | 2015-02-25 | 26,550 | — | $0 | 26,550 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-02-19 | 2015-02-20 | 537 | $401.04 | $215.4K | 46,538 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-02-17 | 2015-02-18 | 825 | $389.11 | $321.0K | 47,075 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2015-02-12 | 2016-03-03 | 9,189 | — | $0 | 18,380 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2015-02-12 | 2016-03-03 | 9,189 | — | $0 | 43,466 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 6,401 | — | $0 | 25,089 | SEC↗ |
| BIIB BIOGEN IDEC INC. | J Other deriv | 2015-02-12 | 2015-02-17 | 4,093 | — | $0 | 20,996 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 9,198 | — | $0 | 18,371 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 9,198 | — | $0 | 43,475 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 4,781 | $392.11 | $1.87M | 47,900 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2015-02-12 | 2015-02-17 | 10,149 | — | $0 | 52,681 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 3,015 | $392.11 | $1.18M | 42,532 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 6,401 | — | $0 | 45,547 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 4,329 | $392.11 | $1.70M | 39,146 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-10 | 2015-02-11 | 18,833 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-10 | 2015-02-11 | 8,871 | $395.13 | $3.51M | 34,277 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-10 | 2015-02-11 | 18,833 | — | $0 | 43,148 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-09 | 2015-02-11 | 11,270 | — | $0 | 11,274 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-09 | 2015-02-11 | 11,270 | — | $0 | 29,255 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-09 | 2015-02-11 | 4,940 | $396.88 | $1.96M | 24,315 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-11-03 | 2014-11-04 | 1,128 | $320.78 | $361.8K | 17,985 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2014-10-14 | 2014-10-16 | 29,412 | — | $0 | 1,303,827 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-10-01 | 2014-10-02 | 1,127 | $330.97 | $373.0K | 19,113 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2014-09-17 | 2014-09-18 | 784 | $58.89 | $46.2K | 2,353 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2014-09-17 | 2014-09-18 | 1,569 | $58.89 | $92.4K | 1,569 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-09-02 | 2014-09-04 | 1,128 | $345.47 | $389.7K | 20,240 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-08-01 | 2014-08-04 | 1,128 | $332.93 | $375.5K | 21,368 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-07-16 | 2014-07-18 | 12,316 | $312.37 | $3.85M | 22,496 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-07-15 | 2014-07-17 | 21,339 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-07-15 | 2014-07-17 | 21,339 | — | $0 | 44,874 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-07-15 | 2014-07-17 | 10,062 | $312.00 | $3.14M | 34,812 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-06-02 | 2014-06-03 | 484 | $318.93 | $154.4K | 23,535 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2014-05-29 | 2014-05-30 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-05-01 | 2014-05-02 | 995 | $285.49 | $284.1K | 24,019 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-05-01 | 2014-05-02 | 486 | $285.87 | $138.9K | 25,656 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-05-01 | 2014-05-02 | 642 | $285.43 | $183.2K | 25,014 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-04-01 | 2014-04-02 | 2,123 | $308.42 | $654.8K | 26,142 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 5,673 | $334.54 | $1.90M | 37,416 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 2,300 | $333.61 | $767.3K | 43,089 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 3,280 | $332.40 | $1.09M | 45,389 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 3,985 | $335.25 | $1.34M | 33,431 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 3,001 | $336.49 | $1.01M | 30,430 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 2,065 | $337.25 | $696.4K | 28,365 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 100 | $338.05 | $33.8K | 28,265 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 700 | $327.76 | $229.4K | 53,689 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 1,200 | $328.38 | $394.1K | 52,489 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 500 | $329.06 | $164.5K | 51,989 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 2,420 | $331.55 | $802.4K | 48,669 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-10 | 2014-03-12 | 900 | $330.65 | $297.6K | 51,089 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-03 | 2014-03-04 | 486 | $335.79 | $163.2K | 54,389 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-03 | 2014-03-04 | 963 | $335.79 | $323.4K | 56,368 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-03 | 2014-03-04 | 1,493 | $335.79 | $501.3K | 54,875 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-02-13 | 2014-02-14 | 486 | $316.81 | $154.0K | 57,331 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2014-02-12 | 2014-02-14 | 31,490 | — | $0 | 31,490 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-12 | 2014-02-14 | 9,189 | — | $0 | 27,569 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-12 | 2014-02-14 | 4,333 | $323.04 | $1.40M | 57,817 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-12 | 2014-02-14 | 9,189 | — | $0 | 62,150 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-02-11 | 2014-02-12 | 1,493 | $314.31 | $469.3K | 52,961 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-02-11 | 2014-02-12 | 963 | $314.31 | $302.7K | 54,454 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-10 | 2014-02-11 | 18,833 | — | $0 | 18,833 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-10 | 2014-02-11 | 8,880 | $315.54 | $2.80M | 55,417 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-10 | 2014-02-11 | 18,833 | — | $0 | 64,297 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-09 | 2014-02-11 | 11,270 | — | $0 | 22,544 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-09 | 2014-02-11 | 4,850 | $315.54 | $1.53M | 45,464 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-09 | 2014-02-11 | 11,270 | — | $0 | 50,314 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2013-12-06 | 2013-12-09 | 21,686 | — | $0 | 21,686 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-11-01 | 2013-11-05 | 1,112 | $245.57 | $273.1K | 39,044 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-11-01 | 2013-11-05 | 1,127 | $245.57 | $276.8K | 40,156 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-10-01 | 2013-10-02 | 1,127 | $242.85 | $273.7K | 42,395 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-10-01 | 2013-10-02 | 1,112 | $242.85 | $270.0K | 41,283 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-03 | 2013-09-04 | 200 | $216.31 | $43.3K | 43,522 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-03 | 2013-09-04 | 912 | $213.30 | $194.5K | 43,722 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-03 | 2013-09-04 | 300 | $216.26 | $64.9K | 44,634 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-03 | 2013-09-04 | 600 | $214.74 | $128.8K | 44,934 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-03 | 2013-09-04 | 227 | $213.80 | $48.5K | 45,534 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-08-01 | 2013-08-02 | 2,239 | $218.82 | $489.9K | 45,761 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-07-16 | 2013-07-18 | 2,239 | $223.94 | $501.4K | 48,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-07-15 | 2013-07-16 | 21,339 | — | $0 | 21,339 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-07-15 | 2013-07-16 | 10,073 | $224.33 | $2.26M | 60,177 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-07-15 | 2013-07-16 | 9,938 | $224.33 | $2.23M | 50,239 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-07-15 | 2013-07-16 | 21,339 | — | $0 | 70,250 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-06-03 | 2013-06-04 | 1,598 | $234.16 | $374.2K | 48,911 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2013-05-23 | 2013-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-01 | 2013-05-03 | 1,598 | $215.39 | $344.2K | 50,509 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-04-01 | 2013-04-02 | 1,598 | $193.66 | $309.5K | 52,107 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-04-01 | 2013-04-03 | 1,598 | $193.66 | $309.5K | 52,107 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-03-01 | 2013-03-04 | 1,598 | $165.30 | $264.1K | 53,705 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-02-13 | 2013-02-14 | 1,598 | $163.39 | $261.1K | 55,303 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2013-02-12 | 2013-02-14 | 36,758 | — | $0 | 36,758 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-02-10 | 2013-02-12 | 18,833 | — | $0 | 37,666 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-02-10 | 2013-02-12 | 18,833 | — | $0 | 65,791 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-02-10 | 2013-02-12 | 8,890 | $164.44 | $1.46M | 56,901 | SEC↗ |
| BIIB BIOGEN IDEC INC. | J Other deriv | 2013-02-09 | 2013-02-12 | 1,503 | — | $0 | 33,814 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-02-09 | 2013-02-12 | 9,767 | — | $0 | 35,317 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-02-09 | 2013-02-12 | 3,723 | $164.44 | $612.2K | 46,958 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-02-09 | 2013-02-12 | 9,767 | — | $0 | 50,681 | SEC↗ |
| BIIB BIOGEN IDEC INC. | G Gift | 2012-11-29 | 2013-01-24 | 5,378 | — | $0 | 40,914 | SEC↗ |
| BIIB BIOGEN IDEC INC. | G Gift | 2012-11-29 | 2013-01-24 | 5,378 | — | $0 | 46,292 | SEC↗ |
| BIIB BIOGEN IDEC INC. | G Gift | 2012-11-29 | 2013-01-24 | 5,378 | — | $0 | 5,378 | SEC↗ |
| BIIB BIOGEN IDEC INC. | G Gift | 2012-11-29 | 2013-01-24 | 5,378 | — | $0 | 5,378 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-11-01 | 2012-11-02 | 400 | $138.64 | $55.5K | 52,498 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-11-01 | 2012-11-02 | 828 | $139.73 | $115.7K | 51,670 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-11-01 | 2012-11-02 | 1,244 | $139.46 | $173.5K | 52,898 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-10-01 | 2012-10-02 | 3,654 | $149.16 | $545.0K | 54,142 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-09-04 | 2012-09-05 | 3,654 | $145.90 | $533.1K | 57,796 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-08-01 | 2012-08-02 | 3,655 | $146.30 | $534.7K | 61,450 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-07-17 | 2012-07-18 | 1,244 | $146.04 | $181.7K | 66,333 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-07-17 | 2012-07-18 | 1,228 | $146.04 | $179.3K | 65,105 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2012-07-16 | 2012-07-17 | 21,339 | — | $0 | 42,678 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-07-16 | 2012-07-17 | 8,780 | $144.61 | $1.27M | 67,577 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-07-16 | 2012-07-17 | 8,899 | $144.61 | $1.29M | 76,357 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2012-07-16 | 2012-07-17 | 21,339 | — | $0 | 85,256 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-07-02 | 2012-07-03 | 1,183 | $143.50 | $169.8K | 63,917 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-06-01 | 2012-06-04 | 1,183 | $128.63 | $152.2K | 65,100 | SEC↗ |
| EXEL EXELIXIS INC | A Award deriv | 2012-05-24 | 2012-05-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2012-02-10 | 2012-02-13 | 18,833 | — | $0 | 56,499 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-02-10 | 2012-02-13 | 7,007 | $118.14 | $827.8K | 66,283 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2012-02-10 | 2012-02-13 | 18,833 | — | $0 | 73,290 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2012-02-09 | 2012-02-10 | 45,084 | — | $0 | 45,084 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2011-07-15 | 2012-02-22 | 8,791 | $104.00 | $914.3K | 54,374 | SEC↗ |